Navigation Links
SYNCHRON LX4201

ProductsSYNCHRON LX4201
Company Beckman Coulter, Inc.
Item SYNCHRON LX4201
Features 
  • Improve turnaround time
  • 42 second critical care panel
  • Automatic checking of serum indices (hemolysis, icterus, lipemia)
  • Multiple tube sizes, including pediatric tubes
  • On-board sample dilution
  • Over-range and correction (ORDAC) detection
  • Clot detection and auto-correction
  • No daily maintenance
Description Designed for the high-volume lab, the SYNCHRON LX4201 simplifies and speeds the entire testing process- performing up to 2,880 tests per hour. By combining the ease and economy of the SYNCHRON LX4201 with broad menu, speed and flexibility, your lab will get what you've come to expect from Beckman Coulter-innovative, reliable systems that harness the Power of ProcessTM.
Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. SYNCHRON CX® 4 Delta
2. SYNCHRON CX 3 Delta
3. SYNCHRON CX 4 PRO
4. SYNCHRON LX® 2000 PRO
5. SYNCHRON CX5 PRO
6. SYNCHRON® CX500 PRO System
7. SYNCHRON LX®20 PRO
8. SYNCHRON CX® 1000 PRO Clinical System
9. SYNCHRON CX®9 PRO Clinical System
10. SYNCHRON LX® 20
11. SYNCHRON CX®4 Super
... provide you with everything you need ... evoked potential, or electro-oculogram. The ultra-bright ... to perform ERGs you never imagined ... negative response, and s-cone ERGs. Wireless ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... designed for high throughput microplate processing. The ... Stacker that handles up to 60 microplates ... model is equipped with a dual direct ... may be interfaced to increase flexibility as ...
... Processor is a precise, reliable and ... has been designed for OEM production. ... customised according to the method bottles ... able to process automatically the whole ...
Medicine Products:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: